<Disease><Name>SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE (SPG5A)</Name><Synonym /><OMIM><Number>270800</Number><URL>http://omim.org/entry/270800</URL></OMIM><Orphanet><Number>100986</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=100986</URL></Orphanet><Protein><Number>Cytochrome P450 7B1</Number><URL>https://www.uniprot.org/uniprot/O75881</URL></Protein><ExPASy><Number>1.14.13.100</Number><URL>http://enzyme.expasy.org/EC/1.14.13.100</URL></ExPASy><Gene>8q12.3</Gene><ICD /><Summary>very rare;autosomal recessive;mutation in the CYP7B1 gene</Summary><Symptoms><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>3460</id><symptom>cognitive impairment / cognitive dysfunction</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3848</id><symptom>gait disturbance</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3888</id><symptom>spastic paraplegia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>7248</id><title>Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial</title><author>Schoels L,</author><journal>Brain</journal><year>2017</year><book /><volume>140</volume><number>12</number><pages>3112-3127</pages><co_aut>et al.</co_aut></literature><literature><id>7247</id><title>Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations</title><author>Arnoldi A,</author><journal>Clin Genet</journal><year>2012</year><book /><volume>81</volume><number>2</number><pages>150-157</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>